BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Y, Feng J, Wang Q, Zhao S, Xu J, Li H. PPAR-γ agonist rosiglitazone ameliorates peritoneal deterioration in peritoneal dialysis rats with LPS-induced peritonitis through up-regulation of AQP-1 and ZO-1. Biosci Rep 2018;38:BSR20180009. [PMID: 29871973 DOI: 10.1042/BSR20180009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Li Z, Feng J, Yang S, Meng P, Li J, Li H, Gao X, Zhang Y. Lipopolysaccharide-induced inflammation in human peritoneal mesothelial cells is controlled by ERK1/2-CDK5-PPARγ axis. Ann Transl Med 2021;9:850. [PMID: 34164484 DOI: 10.21037/atm-21-1623] [Reference Citation Analysis]
2 Marchant V, Tejera-Muñoz A, Marquez-Expósito L, Rayego-Mateos S, Rodrigues-Diez RR, Tejedor L, Santos-Sanchez L, Egido J, Ortiz A, Valdivielso JM, Fraser DJ, López-Cabrera M, Selgas R, Ruiz-Ortega M. IL-17A as a Potential Therapeutic Target for Patients on Peritoneal Dialysis. Biomolecules 2020;10:E1361. [PMID: 32987705 DOI: 10.3390/biom10101361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]